| pubmed-article:6626320 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6626320 | lifeskim:mentions | umls-concept:C0019168 | lld:lifeskim |
| pubmed-article:6626320 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:6626320 | lifeskim:mentions | umls-concept:C0020861 | lld:lifeskim |
| pubmed-article:6626320 | lifeskim:mentions | umls-concept:C1704241 | lld:lifeskim |
| pubmed-article:6626320 | lifeskim:mentions | umls-concept:C2826293 | lld:lifeskim |
| pubmed-article:6626320 | lifeskim:mentions | umls-concept:C1742737 | lld:lifeskim |
| pubmed-article:6626320 | lifeskim:mentions | umls-concept:C0728938 | lld:lifeskim |
| pubmed-article:6626320 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:6626320 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6626320 | pubmed:dateCreated | 1983-12-20 | lld:pubmed |
| pubmed-article:6626320 | pubmed:abstractText | HBsAg bound to IgM was detected in serum of HBsAg carriers with a radioimmunoassay based on selective absorption of the immunoglobulin on a solid phase coated with antiserum to human IgM. High titers of HBsAg/IgM were found in sera with the highest HBsAg binding capacity of polymerized human serum albumin (poly-HSA) and of C1q. These findings and the inhibition of HBsAg/IgM reaction by addition of purified poly-HSA suggest that the IgM component of the complex might bind to poly-HSA fixed on to HBsAg particles and possibly represent antibody to the modified plasma protein. HBsAg/IgM was detected in 95 (87%) patients with acute HBsAg positive hepatitis during the acute phase of infection and persisted after the fourth week only in patients who developed chronic liver disease. HBsAg/IgM were detected in one out of 15 carriers of the HBsAg with superimposed Non B hepatitis. HBsAg/IgM were also present in 76% to 100% of sera from chronic carriers without any relation to the extent of viral replication and to presence of severity of liver disease. Persistence of HBsAg/IgM in patients with acute hepatitis B may provide a useful tool to predict transition of HBV infection to chronicity. | lld:pubmed |
| pubmed-article:6626320 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6626320 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6626320 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6626320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6626320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6626320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6626320 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6626320 | pubmed:month | May | lld:pubmed |
| pubmed-article:6626320 | pubmed:issn | 0021-2547 | lld:pubmed |
| pubmed-article:6626320 | pubmed:author | pubmed-author:RizziRR | lld:pubmed |
| pubmed-article:6626320 | pubmed:author | pubmed-author:CaneseM GMG | lld:pubmed |
| pubmed-article:6626320 | pubmed:author | pubmed-author:BoninoFF | lld:pubmed |
| pubmed-article:6626320 | pubmed:author | pubmed-author:PallaMM | lld:pubmed |
| pubmed-article:6626320 | pubmed:author | pubmed-author:AlmiPP | lld:pubmed |
| pubmed-article:6626320 | pubmed:author | pubmed-author:TotiMM | lld:pubmed |
| pubmed-article:6626320 | pubmed:author | pubmed-author:TouscozGG | lld:pubmed |
| pubmed-article:6626320 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6626320 | pubmed:day | 31 | lld:pubmed |
| pubmed-article:6626320 | pubmed:volume | 62 | lld:pubmed |
| pubmed-article:6626320 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6626320 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6626320 | pubmed:pagination | 137-44 | lld:pubmed |
| pubmed-article:6626320 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:6626320 | pubmed:meshHeading | pubmed-meshheading:6626320-... | lld:pubmed |
| pubmed-article:6626320 | pubmed:meshHeading | pubmed-meshheading:6626320-... | lld:pubmed |
| pubmed-article:6626320 | pubmed:meshHeading | pubmed-meshheading:6626320-... | lld:pubmed |
| pubmed-article:6626320 | pubmed:meshHeading | pubmed-meshheading:6626320-... | lld:pubmed |
| pubmed-article:6626320 | pubmed:meshHeading | pubmed-meshheading:6626320-... | lld:pubmed |
| pubmed-article:6626320 | pubmed:meshHeading | pubmed-meshheading:6626320-... | lld:pubmed |
| pubmed-article:6626320 | pubmed:meshHeading | pubmed-meshheading:6626320-... | lld:pubmed |
| pubmed-article:6626320 | pubmed:meshHeading | pubmed-meshheading:6626320-... | lld:pubmed |
| pubmed-article:6626320 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6626320 | pubmed:articleTitle | HBsAg/IgM complexes in serum of HBsAg carriers: partial characterization and clinical significance. | lld:pubmed |
| pubmed-article:6626320 | pubmed:publicationType | Journal Article | lld:pubmed |
